Buren of Hospital Admissions for Cervical Cancer in Spain During 1999-2002

Â, Gil; San-Martı́n, M.; R, Gil; Hernández,; Ribes, Josepa; González, Antonio

doi:10.4161/hv.4875

Cited by 12 publications

(11 citation statements)

References 24 publications

(32 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean (SD) age was 48.7 [12] years. The total numbers of participants in the age range of 18–64 years were 204 (89.9%).…”

Section: Resultsmentioning

confidence: 99%

“…According to a population-based study in Spain, during a four year period (1999–2002), the mean cost of hospitalization due to cervical cancer and carcinoma in situ is 3,098 Euro and 2,192 Euro respectively [12]. Another retrospective study done in Tunisia has shown that the direct medical care cost of cervical cancer as ranging from 431 to 4143 Euro [13].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study

Hailu

Mariam

2013

BMC Cancer

View full text Add to dashboard Cite

BackgroundCervical cancer is a leading cause of death from cancer among women in low-resource settings, affecting women at a time of life when they are critical to social and economic stability. In addition, the economic burden is important for policy formulation. The aim of this study is to estimate patient side cost and to determine predictors of its variation for the treatment of cervical cancer.MethodsAnalytic cross sectional study involving 227 cervical cancer cases at Tikur Anbessa Hospital, Ethiopia was conducted. Cost estimation was based on patients' perspective and using the prevalence-based model as a time frame. Productivity losses were estimated from lost working days.ResultsThe mean outpatient cost per patient for cervical cancer was $407.2 (Median = $206.9). Direct outpatient cost (Mean = $334.2) takes the largest share compared with the indirect counterpart ($150). The outpatient cost for half of the respondent falls in a range between $93.7 and $478. The mean inpatient cost for hospitalized patients was $404.4. The average direct inpatient cost was $329 (74% medical costs and 26% non medical costs). The mean value for total inpatient cost for half of the respondents was in the range of $133.5 and $493.9. For every additional day of inpatient hospital stay, there is a daily incremental inpatient cost of $4.2.ConclusionAs has been found in other studies, our findings revealed that cervical cancer creates an immense financial burden on patients. Primary prevention measures, vaccination against HPV and screening, should be initiated and expanded to reduce morbidity from cervical cancer and subsequent costs in both human lives and money resources. Control of co-morbidity and complication should be emphasized during management of cervical cancer patients. Capacitating regional hospitals and provision of low cost or fee exemption schemes should be arranged and strengthened.

show abstract

“…The mean (SD) age was 48.7 [12] years. The total numbers of participants in the age range of 18–64 years were 204 (89.9%).…”

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study

Hailu

Mariam

2013

BMC Cancer

View full text Add to dashboard Cite

show abstract

“…Furthermore, this database has been shown to be a reliable tool for enumerating cases of different infectious diseases that required hospitalization. 16 This epidemiological retrospective survey aims to provide population-based estimates of the burden of hospitalization for anus malign neoplasm in the general population and penis malign neoplasm in men in Spain during a 12-y period (1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008) Results Anus malignant neoplasm. Hospital discharges for anus malignant neoplasm during the 12-y study period were studied.…”

mentioning

confidence: 99%

The burden of hospitalizations for anus and penis neoplasm in Spain (1997–2008)

Gil-Prieto

Ester

Álvaro-Meca

et al. 2012

Human Vaccines & Immunotherapeutics

Self Cite

View full text Add to dashboard Cite

“…This study, like the previous study, used a hospital discharge database, Conjunto Mínimo Básico de Datos (CMBD), that has proven to be useful for the evaluation of HPV related hospitalizations and other hospitalization associated diseases [11] , [17] , [18] .…”

Section: Introductionmentioning

confidence: 99%

Hospitalization burden associated with malignant neoplasia and in situ carcinoma in vulva and vagina during a 5-year period (2009–2013) in Spain: An epidemiological study

López

Miguel

Pascual-García

et al. 2018

Papillomavirus Research

Self Cite

View full text Add to dashboard Cite

BackgroundVulvar and vaginal cancers are considered rare cancers in women. Human Papillomavirus is responsible for 30–76% of them. The aim of this study was to describe the burden of hospital admissions by malignant neoplasia (MN) and in situ carcinoma (ISC) of vulva and vagina from 2009 to 2013, in SpainMethodsThis observational, descriptive study used discharge information obtained from the national surveillance system for hospital data, Conjunto Mínimo Básico de Datos, CMBD, provided by the Ministry of Health.ResultsFrom 2009–2013, we found 9,896 hospitalizations coded as MN or ISC of vulva and vagina. Mean age of hospitalization was 69.94 ± 15.16 years; average length of hospital stay (ALOS) was 10.02 ± 12.40 days, and mean hospitalization costs were 5,140.31 ± 3,220.61 euros. Mean hospitalization rate was 9.874 per 100,000 women aged >14 years old (95% CI: 9.689–10.058); mean mortality rate was 0.932 per 100,000 women aged >14 years old (95% CI: 0.872–0.991) and mean case fatality rate was 9.438% (95% CI: 8.862–10.014).ConclusionMN and ISC of vulva and vagina are responsible for a considerable hospitalization burden. Information about these hospitalizations could be useful for cost effectiveness analysis and monitoring of HPV vaccination effectiveness.

show abstract

Buren of Hospital Admissions for Cervical Cancer in Spain During 1999-2002

Cited by 12 publications

References 24 publications

Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study

Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study

The burden of hospitalizations for anus and penis neoplasm in Spain (1997–2008)

Hospitalization burden associated with malignant neoplasia and in situ carcinoma in vulva and vagina during a 5-year period (2009–2013) in Spain: An epidemiological study

Contact Info

Product

Resources

About